Search results
Results from the WOW.Com Content Network
In a new study published in Annals of Surgery, Mayo Clinic researchers analyzed the results of a cross-sectional survey of pancreatic cancer survivors. They found that patients — who were, on average, five years post-surgery — reported excellent quality of life.
LOS ANGELES, Calif. – (January 17, 2024) – The five-year survival rate for pancreatic cancer has increased to 13%, up for the third year in a row according to the American Cancer Society’s Cancer Facts & Figures 2024 released today.
The SEER database tracks 5-year relative survival rates for pancreatic cancer in the United States, based on how far the cancer has spread. The SEER database, however, does not group cancers by AJCC TNM stages (stage 1, stage 2, stage 3, etc.).
The average lifetime risk of pancreatic cancer is about 1 in 56 in men and about 1 in 60 in women. But each person’s chances of getting this cancer can be affected by certain risk factors. For statistics related to survival, see Pancreatic Cancer Survival Rates by Stage.
American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.
LOS ANGELES, Calif. – (Jan. 12, 2023) – American Cancer Society’s (ACS) Cancer Facts & Figures 2023 report, released today, shows that the five-year survival rate for pancreatic cancer has reached a new all-time high of 12%, an increase of one percentage point from last year.
Using statistical models for analysis, age-adjusted rates for new pancreatic cancer cases have been rising on average 0.9% each year over 2012–2021. Age-adjusted death rates have been rising on average 0.2% each year over 2013–2022. 5-year relative survival trends are shown below.